Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
暂无分享,去创建一个
R. Chilengi | S. Bosomprah | N. Sukwa | M. Simuyandi | N. Laban | M. Goodier | Innocent Mwape | Masuzyo Chirwa-Chobe | Mwelwa Chibuye | Cynthia Mubanga | Adriace Chauwa | R. Velu | Chikumbutso Chipeta | Katanekwa Njekwa
[1] R. Chilengi,et al. Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants , 2021, Vaccine.
[2] Benjamin Lee. Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines , 2020, Human vaccines & immunotherapeutics.
[3] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[4] E. Burnett,et al. Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006-2019. , 2020, The Journal of infectious diseases.
[5] G. Kang. Improving the performance of oral rotavirus vaccines. , 2019, The Lancet. Global health.
[6] Tamer Farag,et al. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS) , 2019, The Lancet. Global health.
[7] T. H. Nguyen,et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet. Infectious diseases.
[8] K. Neuzil,et al. Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants , 2018, The Journal of infectious diseases.
[9] R. Haque,et al. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] E. Burnett,et al. Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality. , 2017, Vaccine.
[11] J. Tate,et al. Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R. Chilengi,et al. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants , 2016, PloS one.
[13] Mustafizur Rahman,et al. Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial , 2016, The Journal of infectious diseases.
[14] Inacio Mandomando,et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.
[15] K. Soares-Weiser,et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. , 2019, The Cochrane database of systematic reviews.
[16] Manish M Patel,et al. Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis , 2012, PLoS medicine.
[17] S. Madhi,et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial , 2012, BMC Infectious Diseases.
[18] D. Bernstein,et al. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. , 2004, The Journal of infectious diseases.